A Phase 1, Study to Evaluate HTI-2088 Tablet
Clinical trial NCT03203811 · COMPLETED
Trial details
- NCT number
- NCT03203811
- Sponsor
- Hengrui Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-17
- Primary completion
- 2017-10-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.